Scientology Donor Bob Duggan's Company Makes $975 Million Deal With Johnson & Johnson/Janssen

Discussion in 'Media' started by Harold Hinkubah, Dec 10, 2011.

  1. Ok, so...if a bigshot, famous Scientologist runs a BigPharma company that cures cancer WITH DRUGS, how the fuck is DM gonna spin that shit!? That would be AWESOME; a cure for cancer AND an major fucking headache for LRonBots all at the same time :)
    • Like Like x 1
  2. Anonymous Member

    I think it's a fraud. Where is the research and names of people involved? This sort of thing has happened before and, since when do we trust scientologists about anything?
  3. YSOSRS? Ofcourse its a scam....that got a 900+ million dollar investment....for a project without research or a credentials list....? You really believe that anyone would part with that kind of money without some level of research first? Just because google cant find it doesnt mean it is nonexistent.
  4. Anonymous Member

  5. Squirrel King Member

    Exactly. Not to pick on Christians, but since they are so numerous and many of us are to some degree we can relate to the thinking pattern of the more zealous members:

    Something good happens: bumper crop = God's blessing (not because of an extended growing season due to el Nino)
    Something bad happens to themselves: Tornado destroys house = Random chance and possible falling away from the church. (Although surviving while others are killed is attributed to God's blessings.)
    Something bad happens to others: Tornado destroys house = Sin, Satan, God's wrath, karma (not because of random chance)

    In Scientology:
    Something good happens: it is because of the correct application of the tech and L. Ron Hubbard
    Something bad happens to themselves: Random chance, misapplication of the tech, body thetans, engrams
    Something bad happens to others: Misapplication of the tech, Potential Trouble Source, Suppressive Person

    And these "success" stories are very critical to the process of brainwashing. The North Koreans and Chinese used this to great effect with American POWs. By writing down a success story they had to 1) commit a position to paper and 2) think of supporting arguments. Thus reinforcing their new beliefs and allowing them to give specific reasons for their successes. (And we know how zealous people get when they encounter a new product or idea.) Now here's where the first hurdle of brainwashing takes place: you need to have a relatively trusting victim. To use the Korean War example: most American POWs knew what they were doing was a sham and many just went along with it to get a few token rewards. Others who were more sympathetic to the communist ideas or had more criticisms of American culture and more open to the ideas were more apt to become fully compliant with their captors. This is important because brainwashing (as well as torture) will not work on someone who is hostile and defiant of the group attempting to gain compliance in their mind. (You can compare the results between the Norfolk Four --those who trusted the interrogators with Operation Demetrius -- those who hated theirs.) I also believe this is also at play in deprogramming an idea or belief. It takes a long time to shake out these ideas and when faced with direct examples of contradictions in logic and facts, brainwashed victims retreat into comfortable thought patterns and employ cognitive dissidence protecting themselves from the new information.

    And at this stage it is extremely hard to get the misattribution out of the mind of the brainwashed victim. We can show them all the empirical evidence we want, but they have already trained their minds to distrust the mainstream world. (Like Young Earth Creationists dismissing the fossil record.) Add to this the cost-sink in time and money and associated emotional strength needed to admit that you have been swindled out of hundreds of thousands of dollars and it becomes very difficult to free yourself from those thought patterns.
    • Like Like x 1
  6. Anonymous Member

    Annual Financials for Pharmacyclics Inc

    SG&A Expense 28.08M 25.16M 21.39M 24.68M 43.32M

    Research & Development 21.12M 18.18M 13.95M 17.36M 34.48M

    Other SG&A 6.96M 6.98M 7.44M 7.33M 8.83M

    Other Operating Expense 0 0 0 0 0

    Unusual Expense 0 0 740,000 6,000 0

    EBIT after Unusual Expense 0 0 (740,000) (6,000) 0

    Non Operating Income/Expense 0 0 0 6,000 2,000

    Non-Operating Interest Income 2.18M 1.21M 137,000 81,000 169,000

    Equity in Affiliates (Pretax) 0 0 0 0 0

    Interest Expense 0 0 606,000 43,000 0

    Gross Interest Expense 0 0 606,000 43,000 0

    Interest Capitalized 0 0 0 0 0

    Pretax Income (26.22M) (24.3M) (22.9M) (15.57M) (35.2M)
  7. Anonymous Member

  8. The trophy he received a few years ago (see previous photo) was for being the largest donor to IAS but I don't know how much that would be.
  9. Anonymous Member


    Conference Call Details

    The Company will be holding a conference call on Wednesday December 14, 2011 at 4:30pm ET. To participate in the conference call, please dial 1-877-407-8133 for domestic callers and 1-201-689-8040 for international callers. To access the live audio broadcast or the subsequent archived recording, log on to . The archived version of the webcast will be available for 30 days on the Investor Relations section of the company's Web site at .
    • Like Like x 2
  10. Anonymous Member

    Anonymous said: ↑

    Other SG&A 6.96M 6.98M 7.44M 7.33M 8.83M

    Wonder what "other" means. How much did scientologist Bob Duggan giveto super powers? 12 million. How much did he givefor other scientology causes?

    These "other" expenses are years 2007 - 2011.

    Bob Duncan became CEO in 2007, and OT8 Rainer Ramses became VP of finances in 2008. Wonder what years Bob made his donations (and total amount) to Scientology.

    This would be a cool question to ask, if anyone's going to call the LIVE BROADCAST today.
  11. Anonymous Member

    I presume luck has a lot to do with it too - being in the right place at the right time. Not to mention just plain old hard work and perseverence.
  12. Anonymous Member

    Robert Duggan's wife Patricia Duggan, is listed as the only patron of scientology orphan scam in Haiti (grodysh dot org)


    Art Durivage, Wide Music Rockin Around the Clock Radio

    Brad Kugler, DV&A Inc.

    Budget Storage, Clearwater, FL

    Dan Martin , All Round Repairs, Clearwater, FL

    David Tapia, Allstate Insurance

    Dr. David Minkoff, Lifeworks Wellness Center

    Dr. France Carpentier, Family Life Chiropractic Center

    Dr. Jean Maurice Dure, Family Practice

    Dr. Jonathan J. Bromboz, Clinique for Aesthetic & Natural Dentistry

    Dr. Rick Argall, Family Life Chiropractic Center

    Fran M. Haasch, Attorney at Law

    Gini Curtis, Asst. CS Manager, BlendTec Blenders

    Holly Haggerty, Community Learning Center of Clearwater

    Kim Bright, BrightCore Nutrition

    Life Is Good, Inc.

    Patrick Clouden, Accelerated Training Solutions

    Paul Ash, President, Sam Ash Music Corp.

    Randy Mortensen, Worldwide Village

    Reliable Movers, Clearwater, FL

    Rev. Dr. Frantz St. Pierre, French-speaking Baptist Church

    Of Bridgeport, CT

    Sarah Ehrlich, Help For Orphans


    Patricia Duggan.
  13. Anonymous Member

    With all those millions of $$$$ the Duggan's have, and the orphans have no beds or shoes? Something ain't right here. Or I'm really stupid.
  14. I was looking for something to verify that this is Robert "Bob" Duggan's wife who is referred to as "Trish" in Scientology, I found this:
  15. fify
  16. Anonymous Member

    I'm waiting for Mr. Duggan to strike a blow against the psychs.
  17. Anonymous Member


    Know all by these presents, that the undersigned hereby authorizes Richard A. Miller, M.D. and Leiv Lea of Pharmacyclics, Inc. (the "Company"), to execute for and on behalf of the undersigned, in the undersigned's capacity as a director of the Company, Forms 3, 4 and 5, and any amendments thereto, and cause such form(s) to be filed with the United States Securities and Exchange Commission pursuant to Section 16(a) of the Securities Act of 1934, relating to the undersigned's beneficial ownership of securities in the Company. The undersigned hereby grants to each such attorney-in-fact full power and authority to do and perform any and every act and thing whatsoever requisite, necessary, or proper to be done in the exercise of any of the rights and powers herein granted, as fully to all intents and purposes as the undersigned might or could do if personally present, with full power of substitution or revocation, hereby ratifying and confirming all that such attorney-in-fact, or such attorney-in-fact's substitute or substitutes, shall lawfully do or cause to be done by virtue of this power of attorney and the rights and powers herein granted. The undersigned acknowledges that the foregoing attorneys-in-fact, in serving in such capacity at the request of the undersigned, are not assuming, nor is the Company assuming, any of the undersigned's responsibilities to comply with Section 16 of the Securities Exchange Act of 1934.

    This Power of Attorney shall remain in full force and effect until the undersigned is no longer required to file Forms 3, 4 and 5 with respect to the undersigned's holdings of, and transactions in, securities issued by the Company, unless earlier revoked by the undersigned in a signed writing delivered to the foregoing attorneys-in-fact.

    IN WITNESS WHEREOF, the undersigned has caused this Power of Attorney to be executed as of this 24th day of July, 2008.

  18. Anonymous Member

  19. Anonymous Member

    Email sent today to (Pharmacylics)

    Please pass along this message to Scientologists Robert Duggan and Rainer (Ramses) Erdtmann. Urgent. Thank you.

    Dear Friend,

    I am emailing you as a friend and fellow Scientologist. As we enter a new year, it is hoped that 2012....
    • Like Like x 1
  20. Gottabrain Member

  21. Intelligence Member

    I agree^^^ AND not just a big Pharma company, but Johnson & Johnson, a Psych Drug pharmacutical company.


  22. Anonymous Member

    Pharmacyclics Inc is owned and run by Scientologists, warning to investors!!!
  23. Anonymous Member

    How do we get this to appear on a Google search? I only find this info if I'm googling Pharmacyclics Inc with scientology.
  24. Herro Member

    Why does that matter?
  25. Robert (Bob) Duggan is possibly Scientology's largest donor. For me personally this shows very poor judgement on his part so I wouldn't invest in a company he was CEO and the major shareholder of.
  26. Anonymous Member

    Here's what employees have to say about Pharmacyclics:

    Cons Management seems to be very into status symbols and making sure staff knows its place. A lot of effort has gone into making executive offices nicer than others with special glass and chairs that others can't have. This creates a have vs. have-not mentality that is not good for morale. A real shame since this takes away from so many positives the company has.

    Advice to Senior Management Remember you are successful due to the hard work of all the people that work for you. When you lavish yourselves with lots of extras, it damages morale in ways that are very hard to repair. The more you can provide the same benefits to everyone, the better it will be.

    Cons VERY VERY poor leadership in clinical development and finance. Poor judgement in hiring decisions. Sr leadership often ignore team recommendations. Make poor development decisions without analyzing data & outlook. Not a place to go if you are a project manager who like to bounce ideas off because it will be either ignored or trumped for personal agendas.

    Advice to Senior Management Get rid of the CMO
    • Like Like x 1
  27. Anonymous Member

    Lori Kunkel, MD - Chief Medical Officer

    Dr. Lori Anne Kunkel spent ten years in academic/clinical medicine and served as a faculty member in the Division of Hematology/Oncology Bone Marrow transplant

    prior to joining the international

    unit at

    Los Angeles

    University of California,

    biotechnology industry in 1995. Since then, she has held executive positions in a variety of companies that have provided her extensive experience in developing






    responsibilities have included clinical, regulatory, medical affairs and licensing. She



    large biotechnology corporations (Genentech/Roche,


    Novartis), and has served as Chief Medical Officer in start-up biotechs (ACT biotech, Syndax, Proteolix (acquired by Onyx) and Clinical Vice President at Genitope and Xencor. She has led US INDs, been directly involved in multiple EU and US strategic regulatory meetings, and secured Orphan Drug designations, Special Protocol Assessments, and Scientific Advice on numerous agents. Most recently she has been the principal of D2D, LLC, a consulting company that she founded. She has participated as a strategic clinical advisor and consultant to several corporations including Aton (acquired by Merck), DNAX (Schering Plough), Salmedix/Cephalon, Zymogenetics, Onyx, Raven, and Xoma, as well as a consultant for Boston and Bay area Venture Capital firms. Dr. Kunkel holds a Bachelor of Arts in Biology from University of California, San Diego; a medical degree from University of Southern California. She is board certified in Internal Medicine and Oncology.
  28. Anonymous Member

    These are employee reviews from this month! Sounds like Bob Duggan's company is beginning to unravel.
  29. Anonymous Member

    Cons VERY VERY poor leadership in clinical development and finance.

    That's because OSA operative Rainer (Ramses) Erdtmann is in charge of finance.

    Btw, I talked to an insider at pcyc who said everyone there read the Debbie Cook email, but no further comment.
    • Like Like x 1
  30. If possible could you ask this "insider" if most of the employees are aware that Bob Duggan has donated 50+ million to Scientology?
  31. Pharmacyclics_Robert-Duggan.jpg
    Robert W. Duggan, CEO and chairman of the board, Pharmacyclics Inc.
  32. Pharmacyclics' fifth patient enrollment in phase III Resonate study triggers milestone payment from Janssen

    Sunnyvale, California
    Friday, August 03, 2012, 18:00 Hrs [IST]

    Pharmacyclics, Inc.,. a clinical-stage biopharmaceutical company, has enrolled fifth patient for the international phase III randomized, multicentre, open-label clinical trial, Resonate (PCYC-1112), of ibrutinib versus ofatumumab for patients with relapsed or refractory chronic lymphocytic leukaemia or small lymphocytic lymphoma (CLL/SLL).

    The enrollment of the fifth patient has subsequently triggered a $50 million milestone payment obligation from Janssen Biotech, Inc. (Janssen), one of the Janssen Pharmaceutical Companies of Johnson & Johnson and the worldwide collaborator on ibrutinib in oncology. As Pharmacyclics or Janssen initiate further phase III trials in specific indications and enrol the 5th patient, additional milestone payments of $50 million may be triggered up to a total of $250 million. We anticipate an additional phase III trial milestone payment during calendar 2013.

    "This is the first phase III trial of a broad development plan to evaluate the potential of ibrutinib in a range of haematologic malignancies," said Bob Duggan, chairman and CEO of Pharmacyclics. "We are very excited to have moved this molecule in such short time from first patient dosed in the spring of 2009 to now a pivotal phase III clinical trial. The initiation of this first phase III trial with ibrutinib is a testament to the hard work and focused efforts of the entire Pharmacyclics team, our external collaborators and the support and cooperation we enjoy with our partner Janssen. We look forward with confidence to continued progress."
  33. Ogsonofgroo Member

    I blame LRon's mom..... she didn't drop him on his head near enough...
    • Funny Funny x 1
  34. RightOn Member

    All the money in the world can't cure cancer from asbestos
  35. Anonymous Member

    Pharmacyclics stock sags on disappointing clinical trial results

    Silicon Valley / San Jose Business Journal by Diana Samuels, Technology Reporter
    Date: Monday, November 5, 2012, 2:33pm PST
    Pharmacyclics, led by CEO Robert Duggan (center), saw its stock drop significantly Monday after new trial data was released about the drug it's developing.

Share This Page

Customize Theme Colors


Choose a color via Color picker or click the predefined style names!

Primary Color :

Secondary Color :
Predefined Skins